Role of DNA Methylation in the Pathogenesis of Skin Disorders: Mechanisms, Inhibitors of Methylation‐Related Enzyme, and Molecular Docking Studies
BioMed Research International · 2025
DOI: 10.1155/bmri/7002918 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BioMed Research International, 2025. Verfasst von Anchal Rani und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Allied and Health Care Sciences, GNA University, Phagwara, India. Hauptthemen laut MEDLINE: DNA Methylation, Skin Diseases, Molecular Docking Simulation, Enzyme Inhibitors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
DNA methylation is an epigenetic mechanism modulating gene expression without altering the genetic sequence and plays a significant role in skin disorders. Methylation patterns on specific genes can lead to either overexpression or suppression, impacting cellular functions critical to skin health. Skin disorders such as atopic dermatitis, eczema, androgenetic alopecia, systemic lupus erythematosus, psoriasis, and systemic sclerosis have been linked to abnormal DNA methylation, which contributes to disease progression through immune dysregulation, barrier dysfunction, and inflammation. The methylation of genes like S100A2 and FCERIG in atopic dermatitis or FLG in eczema illustrates how modifications affect immune pathways and skin integrity. Recent advancements in DNA methylation analysis have enhanced the precision of detecting methylation levels and their influence on gene expression, leading to a deeper understanding of disease mechanisms. Identifying aberrant methylation patterns offers potential biomarkers for early diagnosis and therapeutic targets, especially in autoimmune and inflammatory skin diseases. Further exploration of epigenetic changes could pave the way for innovative treatments, addressing underlying epigenetic disruptions that characterize these conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Allied and Health Care Sciences, GNA University, Phagwara, India.
- School of Pharmacy, GNA University, Phagwara, India.
- Research and Development Cell, Lovely Professional University, Phagwara, Punjab, India.
- Sharda School of Allied and Healthcare Sciences, Sharda University, Greater Noida, Uttar Pradesh, India.
- Department of Biological Sciences, Al Hussein Bin Talal University, Maan, Jordan.
- Department of Biochemistry, All India Institute of Medical Sciences, Gorakhpur, India.
ORCID-Profile: Anchal Rani, Rohan Samir Kumar Sachan, Mukesh Kumar, Harsh Sable, Abdel Rahman Mohammad Al Tawaha, Shahid Malik, Arun Karnwal, Tabarak Malik
Zitieren
APA
Rani, A., Kaur, G., Kumar, R., Sachan, R. S. K., Kumar, M., Sable, H., Al Tawaha, A. R. M., Malik, S., Karnwal, A., & Malik, T. (2025). Role of DNA Methylation in the Pathogenesis of Skin Disorders: Mechanisms, Inhibitors of Methylation‐Related Enzyme, and Molecular Docking Studies. BioMed Research International. https://doi.org/10.1155/bmri/7002918
Vancouver
Rani A, Kaur G, Kumar R, Sachan RSK, Kumar M, Sable H, et al. Role of DNA Methylation in the Pathogenesis of Skin Disorders: Mechanisms, Inhibitors of Methylation‐Related Enzyme, and Molecular Docking Studies. BioMed Research International. 2025. doi:10.1155/bmri/7002918
BibTeX
@article{Rani2025,
author = {Rani, Anchal and Kaur, Gagandeep and Kumar, Ravinder and Sachan, Rohan Samir Kumar and Kumar, Mukesh and Sable, Harsh and Al Tawaha, Abdel Rahman Mohammad and Malik, Shahid and Karnwal, Arun and Malik, Tabarak},
title = {Role of DNA Methylation in the Pathogenesis of Skin Disorders: Mechanisms, Inhibitors of Methylation‐Related Enzyme, and Molecular Docking Studies},
journal = {BioMed Research International},
year = {2025},
doi = {10.1155/bmri/7002918}
}
EUVIMED